Venrock Associates VI L.P. 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:05 pm Unchanged |
2022-12-31 | 13G | 10x Genomics, Inc. TXG |
Venrock Associates VI L.P. | 4,828,247 4.900% |
0 (Unchanged) |
Filing |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
Venrock Associates VI L.P. | 4,828,247 5.100% |
-3,000,000 (-38.32%) |
Filing |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
Venrock Associates VI L.P. | 7,828,247 9.100% |
-3,263,569 (-29.42%) |
Filing |